Evercore Wealth Management LLC trimmed its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 18.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,705 shares of the pharmacy operator’s stock after selling 3,317 shares during the quarter. Evercore Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $1,072,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of WBA. Bank of New York Mellon Corp raised its stake in shares of Walgreens Boots Alliance by 71,970.7% in the third quarter. Bank of New York Mellon Corp now owns 11,640,855 shares of the pharmacy operator’s stock valued at $848,617,000 after purchasing an additional 11,624,703 shares in the last quarter. Franklin Resources Inc. raised its stake in Walgreens Boots Alliance by 21.5% during the third quarter. Franklin Resources Inc. now owns 18,789,390 shares of the pharmacy operator’s stock worth $1,369,796,000 after acquiring an additional 3,318,524 shares in the last quarter. LSV Asset Management raised its stake in Walgreens Boots Alliance by 28.5% during the third quarter. LSV Asset Management now owns 11,183,914 shares of the pharmacy operator’s stock worth $815,307,000 after acquiring an additional 2,479,681 shares in the last quarter. FMR LLC raised its stake in Walgreens Boots Alliance by 41.9% during the third quarter. FMR LLC now owns 5,640,694 shares of the pharmacy operator’s stock worth $411,206,000 after acquiring an additional 1,665,402 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec raised its stake in Walgreens Boots Alliance by 11.5% during the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,110,617 shares of the pharmacy operator’s stock worth $666,804,000 after acquiring an additional 1,143,819 shares in the last quarter. Institutional investors and hedge funds own 62.59% of the company’s stock.
WBA has been the subject of several recent analyst reports. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research note on Tuesday, September 25th. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, September 21st. Robert W. Baird increased their price objective on Walgreens Boots Alliance from $64.00 to $69.00 and gave the stock a “neutral” rating in a research note on Tuesday, September 11th. Citigroup increased their price objective on Walgreens Boots Alliance from $69.00 to $76.00 and gave the stock a “neutral” rating in a research note on Friday, October 12th. Finally, Loop Capital increased their price objective on Walgreens Boots Alliance from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Friday, October 12th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have given a buy rating and two have given a strong buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $79.11.
In related news, SVP Kimberly R. Scardino sold 11,970 shares of the firm’s stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $79.79, for a total value of $955,086.30. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of the firm’s stock in a transaction dated Wednesday, October 31st. The shares were sold at an average price of $78.77, for a total value of $4,096,040.00. Following the completion of the transaction, the executive vice president now owns 81,076 shares in the company, valued at approximately $6,386,356.52. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 73,756 shares of company stock valued at $5,824,194. 14.80% of the stock is currently owned by corporate insiders.
Shares of NASDAQ:WBA opened at $81.19 on Friday. Walgreens Boots Alliance Inc has a twelve month low of $59.07 and a twelve month high of $86.31. The firm has a market capitalization of $78.61 billion, a PE ratio of 13.49, a price-to-earnings-growth ratio of 1.29 and a beta of 0.76. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.82 and a quick ratio of 0.38.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. The company had revenue of $33.44 billion during the quarter, compared to analyst estimates of $33.64 billion. Equities analysts anticipate that Walgreens Boots Alliance Inc will post 6.54 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th will be paid a $0.44 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.17%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 29.24%.
WARNING: This report was first posted by American Banking News and is owned by of American Banking News. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/12/08/evercore-wealth-management-llc-sells-3317-shares-of-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: Correction
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.